Skip to main content
Caplight Logo









Indivi

Indivi

Private
BaselHealthcare & Life Scienceshttps://indivi.io

Last Round

VC Round

Nov 12, 2025

Est. Valuation

$175.41M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Indivi is a medical technology company that develops digital biomarkers for clinical research and patient monitoring, enabling precision medicine in neuroscience research and development.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Drug Discovery, Health IoT, Healthcare Analytics, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Data as a Service

AI Layer

Application

Keywords

digital biomarkersneuroscience clinical trialsdigital biomarker platformTechBiodigital endpointsSoftware as a Medical DeviceSaMDsmartphone sensingdecentralized clinical trialsmedical AIeCOACNS trialsgamified cognitive assessmentsdrug development accelerationMultiple SclerosisParkinson's diseaseAlzheimer's diseaseDigital CRO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Indivi Comparables

Compare Indivi with similar companies based on industry and business-model similarity.

Indivi comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Koneksa Health
84%
Altoida, Inc.
83%
Cumulus Neuroscience
78%

Indivi Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundNov 12, 2025
Early FundingAug 31, 2022

Key People

Founding team and executive leadership

Corne de Jong

Chief Financial Officer

Executive Team

Simone Rey-Riek

Chief Operating Officer

Executive Team

Indivi Investors

Notable investors and investment history

Indivi investors
InvestorRounds
Zühlke VenturesEarly Funding
Ava InvestorsVC Round
Leclercq American CapitalVC Round
Lichtsteiner FoundationEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    Monthly visitors increased 51% MoM, reaching 2.4K.

  • Jul 27, 2026

    Open roles increased to 41, 51% of headcount.

Indivi Filings

Explore SEC and related filing metadata, where available.

Indivi filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Indivi's valuation, stock price, and market status.

Is Indivi a public or private company?

Indivi is a private company.

What is the current stock price of Indivi?

Indivi is a private company with no public stock price. No recent secondary market data is available.

How much is Indivi worth (valuation)?

Valuation information for Indivi is not publicly available.

Can I buy Indivi stock?

Indivi shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Indivi's last funding round?

Funding round information for Indivi is not publicly available.

Who are the main investors in Indivi?

Investor information for Indivi is not publicly disclosed.

Will Indivi IPO soon?

No public IPO plans have been announced for Indivi.

How can I track Indivi secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Indivi's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBasel
Employee Range54
Year Founded2012
Last FundingNov 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?